Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Myelodysplastic Syndromes, an Issue of Hematology/Oncology Clinics of North America: Volume 34-2

Myelodysplastic Syndromes, an Issue of Hematology/Oncology Clinics of North America: Volume 34-2

Steensma, David

Hardcover

Series: Clinics: Internal Medicine, Book 34

Medical Reference

ISBN10: 0323722598
ISBN13: 9780323722599
Publisher: Elsevier
Published: Feb 24 2020
Pages: 240
Weight: 1.05
Height: 0.61 Width: 6.11 Depth: 9.11
Language: English
This issue of Hematology/Oncology Clinics, guest edited by David P. Steensma, will cover key topics in Myelodysplastic Syndromes. This issue is one of six selected each year by our series consulting editors, George P. Canellos and Edward J. Benz. Topics discussed in this issue will include: Novel prognostic models for MDS, Evaluating MDS patients with genetic mutations that might be germline, Implications of splicing mutations in MDS for pathophysiology and therapy, Assessing quality of life in MDS/MPN overlap patients, Creation of a clinic for patients with clonal hematopoiesis, Luspatercept in MDS, Prospects for venetoclax in MDS, Treatment of acquired sideroblastic anemias, Treatment of patients with AML arising from MDS, Targeting TP53 mutations in MDS, among others.

Also in

Medical Reference

View All